Dr. Wu is an Internal Medicine doctor with a background in Public Health. Her area of clinical practice involves caring for adults with acute and acute-on-chronic medical conditions. She received a MSPH from Johns Hopkins Bloomberg School of Public Health and subsequently obtained her MD from Harvard Medical School. She completed Internal Medicine residency at Massachusetts General Hospital. She is interested in the use of technology to increase access and delivery of evidence-based, integrative care for those with chronic conditions.
Current role
Medical Director, Clinical Development at Endogena Therapeutics
Medical Director Clinical Development at SCYNEXIS
Medical Director, Clinical Development at Amunix
Medical Director Clinical Development at Hofseth BioCare ASA
Medical Director, Clinical Development at Taiho Oncology, Inc.